Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits
ACS Nano · 2023
DOI: 10.1021/acsnano.3c04884 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Yumin Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Cisplatin, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Collaborative Innovation Center of Suzhou Nano Science and Technology, Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, 199 Ren' ai Road, Suzhou, Jiangsu 215123, People's Republic of Chin…
ORCID-Profile: Zhuang Liu
Förderung
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
- Suzhou Key Laboratory of Nanotechnology and Biomedicine
- New Cornerstone Science Foundation
Zitieren
APA
Wu, Y., Wang, C., Yan, Y., Hao, Y., Liu, B., Dong, Z., Chen, M., Zhu, Y., Liu, N., Feng, L., & Liu, Z. (2023). Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits. ACS Nano. https://doi.org/10.1021/acsnano.3c04884
Vancouver
Wu Y, Wang C, Yan Y, Hao Y, Liu B, Dong Z, et al. Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits. ACS Nano. 2023. doi:10.1021/acsnano.3c04884
BibTeX
@article{Wu2023,
author = {Wu, Yumin and Wang, Chunjie and Yan, Yifan and Hao, Yu and Liu, Bo and Dong, Ziliang and Chen, Minming and Zhu, Yujie and Liu, Nanhui and Feng, Liangzhu and Liu, Zhuang},
title = {Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c04884}
}
EUVIMED